Mayumi Endo is responsible for computational science. She has over 20 years of deep knowledge and experience in computational chemistry for novel drug discovery, and is one of developers of “Computational Quantum Chemistry” Program, Gaussian. Mayumi joined to PRISM BioLab in 2023, and before joining to PRISM BioLab, she worked for Taisho Pharmaceutical Co., Ltd....

Akiyoshi Fujiuchi is responsible for efficacy pharmacology and preclinical research in PRISM BioLab. He has about 30 years of deep knowledge and experience in drug discovery, especially in vivo animal experiments, at RaQualia Pharma as well as Pfizer. He nominated development candidates from internal and external collaborative projects as a lead. He received his BS...

Nobuyuki Hori is responsible for medicinal chemistry. His specialities are organic chemistry and medicinal chemistry. Prior to joining PRISM BioLab, he worked for domestic and global pharmaceuticals in Japan, and engaged in process chemistry and novel drug discovery in infection or metabolic disease area targeting transporters, GPCR, and transcriptional factors. He has led several projects...

Wataru Kawahata is responsible for medicinal chemistry. He has more than 20 years experience in drug discovery research. Prior to joining to PRISM BioLab, he was at Asahi Kasei Pharma for GPCR projects, at Carna Bioscience for kinase projects. He has led the project from the hit finding stage to preclinical stage and identified two...

Yohei Matsuda is responsible for medicinal chemistry and technology platform development. Before joining PRISM BioLab, he worked as a medicinal chemist at Taisho Pharmaceutical Co., Ltd. and engaged in drug discovery research in various disease areas and drug discovery technology development. He was involved in many projects as a chemistry leader and contributed to the...

Takeshi Matsushita is responsible for medicinal chemistry at PRISM BioLab. He started his career as a medicinal chemist at ONO Pharmaceutical Co., Ltd., where he experienced a wide range of drug discovery programs including GPCRs and kinases, and contributed to the discovery of several clinical candidates with disease areas including CNS. Prior to joining to...

Dr. Ivan Plavec serves as a Senior Advisor to PRISM BioLab responsible for alliance management and business development. He has over thirty years of experience in biotechnology and pharmaceutical industry and held positions of Chief Business Officer at ImaginAb, Inc., Vice President of Business Development at BioSeek, Inc. and Asterand plc, Vice President of Technology...

Dr. Hajime Takashima is responsible for all aspects of chemistry and medicinal chemistry in PRISM BioLab. In addition to managing and promoting pipeline projects and collaboration projects with our partners, he oversees in silico drug design, compound management, and intellectual property management. His specialties are medicinal chemistry, organic chemistry, and computational chemistry. Before joinning in...

Dr. Tatsuya Toma is responsible for synthesis and scaffold development as well as medicinal chemistry in PRISM BioLab. Before joining in PRISM BioLab, he had an academic career as an assistant professor at Nagoya University. His research involves total synthesis of complex natural products as well as chemical biology. He received his undergraduate and PhD...

Masataka Umitsu is responsible for protein science and biophysics. He has experienced broad type of research programs in Japan and Toronto/Canada, and drug discovery projects in Japanese biotech, and joined to PRISM BioLab in 2024. He received his bachelor’s degree from International Christian University (ICU), master’s degree from OSAKA UNIVERSITY, and Ph.D. from the University...